Chang Gyu Park Selected Research

Nitrates

4/2018	Impact of Trimetazidine Treatment on 5-year Clinical Outcomes in Patients with Significant Coronary Artery Spasm: A Propensity Score Matching Study.
1/2017	Impact of Diltiazem Alone versus Diltiazem with Nitrate on Five-Year Clinical Outcomes in Patients with Significant Coronary Artery Spasm.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chang Gyu Park Research Topics

Disease

34	Myocardial Infarction 01/2022 - 09/2007
25	Hypertension (High Blood Pressure) 01/2022 - 01/2004
23	Cardiovascular Diseases (Cardiovascular Disease) 10/2021 - 12/2004
19	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 04/2006
15	Coronary Vasospasm (Coronary Artery Vasospasm) 05/2022 - 09/2012
12	Diabetes Mellitus 01/2021 - 09/2012
11	Atrial Fibrillation 12/2020 - 04/2011
8	Stroke (Strokes) 09/2020 - 04/2011
8	Spasm (Spasms) 01/2017 - 10/2007
7	Thrombosis (Thrombus) 09/2020 - 09/2007
6	Chest Pain (Chest Pains) 06/2014 - 02/2007
5	Dyslipidemias (Dyslipidemia) 01/2020 - 06/2010
5	Essential Hypertension 01/2018 - 01/2004
4	Heart Failure 01/2022 - 01/2015
4	Death (Near-Death Experience) 09/2020 - 04/2010
4	Insulin Resistance 01/2020 - 02/2013
4	Pathologic Constriction (Stenosis) 03/2018 - 01/2005
4	ST Elevation Myocardial Infarction 12/2017 - 06/2009
3	Type 2 Diabetes Mellitus (MODY) 09/2021 - 08/2013
3	Hemorrhage 09/2020 - 02/2011
3	Coronary Disease (Coronary Heart Disease) 01/2020 - 02/2007
3	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 08/2018 - 01/2004
3	Infarction (Infarctions) 04/2018 - 12/2004
2	Peripheral Arterial Disease 01/2022 - 12/2011
2	Pain (Aches) 01/2022 - 05/2008
2	Vascular Diseases (Vascular Disease) 01/2018 - 07/2005
2	Hypercholesterolemia 01/2018 - 02/2012
2	Coronary Stenosis (Coronary Artery Stenosis) 07/2017 - 01/2005
2	Inflammation (Inflammations) 11/2015 - 04/2011
2	Cardiac Arrhythmias (Arrythmia) 06/2015 - 04/2011
2	Chronic Limb-Threatening Ischemia 04/2015 - 03/2015
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2011 - 03/2010
1	Arteritis 01/2021
1	Hypertriglyceridemia 01/2021
1	Sleep Apnea Syndromes (Sleep Apnea) 01/2020
1	Hematoma 01/2020
1	Ischemic Stroke 01/2020
1	Heart Arrest (Cardiac Arrest) 11/2019

Drug/Important Bio-Agent (IBA)

20	omega-Chloroacetophenone (Mace)IBA 10/2021 - 01/2013
19	Acetylcholine (Acetylcholine Chloride)FDA Link 04/2018 - 10/2007
13	Antihypertensive Agents (Antihypertensives)IBA 09/2021 - 04/2009
10	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 12/2004
7	C-Reactive ProteinIBA 07/2019 - 12/2004
6	LDL CholesterolIBA 01/2022 - 01/2010
6	Clopidogrel (Plavix)FDA Link 09/2020 - 12/2004
6	oxidized low density lipoproteinIBA 01/2020 - 01/2010
6	LipidsIBA 07/2019 - 02/2012
5	Amlodipine (Norvasc)FDA LinkGeneric 01/2020 - 04/2011
4	CholesterolIBA 01/2022 - 03/2010
4	Atorvastatin (Lipitor)FDA Link 01/2021 - 04/2015
4	Triglycerides (Triacylglycerol)IBA 01/2021 - 12/2011
4	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 06/2019 - 04/2011
4	Sirolimus (Rapamycin)FDA Link 10/2014 - 09/2007
4	Paclitaxel (Taxol)FDA LinkGeneric 10/2014 - 02/2007
4	Phenobarbital (Luminal)FDA Link 06/2014 - 01/2005
3	Cilostazol (Pletal)FDA LinkGeneric 01/2022 - 12/2004
3	Rosuvastatin Calcium (Crestor)FDA Link 01/2021 - 01/2018
3	Uric Acid (Urate)IBA 01/2021 - 03/2010
3	Blood Glucose (Blood Sugar)IBA 01/2020 - 06/2014
3	Glucose (Dextrose)FDA LinkGeneric 06/2018 - 12/2011
3	Lipoprotein(a)IBA 01/2018 - 07/2005
3	Telmisartan (Micardis)FDA Link 11/2016 - 10/2011
3	AdiponectinIBA 08/2013 - 01/2004
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2012 - 12/2004
2	Pharmaceutical PreparationsIBA 01/2020 - 04/2011
2	Diltiazem (Cardizem)FDA LinkGeneric 01/2020 - 01/2017
2	NitratesIBA 04/2018 - 01/2017
2	Angiotensin Receptor AntagonistsIBA 12/2017 - 01/2016
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2017 - 01/2016
2	amlodipine-losartan drug combinationIBA 10/2017 - 06/2012
2	Valsartan (Vals)FDA Link 01/2016 - 10/2011
2	Biomarkers (Surrogate Marker)IBA 11/2015 - 04/2011
2	HDL CholesterolIBA 07/2014 - 02/2012
2	P-SelectinIBA 04/2011 - 12/2004
2	Heparin (Liquaemin)FDA LinkGeneric 04/2010 - 02/2007
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022
1	renexinIBA 01/2022
1	hydroxyethyl methacrylate (HEMA)IBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 09/2020
1	Meloxicam (Mobic)FDA LinkGeneric 01/2020
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2020
1	Celecoxib (Celebrex)FDA Link 01/2020
1	Nebivolol FDA Link 01/2020
1	Insulin (Novolin)FDA Link 01/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2020
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 07/2019

Therapy/Procedure

27	Percutaneous Coronary Intervention 09/2020 - 01/2005
18	Therapeutics 01/2021 - 06/2009
15	Drug-Eluting Stents 05/2022 - 01/2005
11	Stents 09/2020 - 09/2005
9	Catheter Ablation 12/2020 - 04/2011
3	Surgical Amputation (Amputations) 01/2021 - 03/2015
2	Cardiac Rehabilitation 12/2021 - 01/2020
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 02/2007 - 01/2005
1	Catheters 01/2021
1	Secondary Prevention 01/2021
1	Denervation 01/2021
1	Limb Salvage 01/2021